UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 4, 2004
------------
ENDOVASC, INC.
(Exact Name of Registrant as Specified in Its Charter)
NEVADA
(State or Other Jurisdiction of Incorporation)
000-28371 76-0512500
(Commission File Number) (IRS Employer Identification No.)
550 CLUB DRIVE, SUITE 440
MONTGOMERY, TEXAS 77316
(Address of Principal Executive Offices) (Zip Code)
(936) 582-5920
(Registrant's Telephone Number, Including Area Code)
ITEM 5. OTHER EVENTS.
On Wednesday, May 26, 2004, David P. Summers tendered his resignation, in
writing, from all positions with Endovasc, Inc., effective close of the business
day, May 27, 2004.
A Special Meeting of the Board of Directors was duly noticed, called and
held. The resignation of Dr. David P. Summers was accepted by the Board of
Directors, effective, May 27, 2004.
Endovasc, Inc. will continue to concentrate its efforts on the Human
Clinical Trials and Research and focus on bringing these products to market.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereto duly authorized.
ENDOVASC, INC.
Date: June 4, 2004 By: /s/ Diane Dottavio
------------ ------------------------------
Diane Dottavio,
Chief Executive Officer